Revivo Therapeutics Alternatives & Competitors
12 companies similar to Revivo Therapeutics — Clinical stage biotechnology company with a new class of drugs targteting cognit...
Companies similar to Revivo Therapeutics
Bionure
Clinical stage biotech developing new drugs for CNS diseases.
Barcelona, Spain
AnnJi Pharmaceutical Co., Ltd.
Taiwan's Leading New Drug Developer In Dermatology & Neurology
Taiwan
Atom Therapeutics
Atom Therapeutics Co., Ltd
Suzhou, China
Treadwell Therapeutics, Inc.
The Path to Better
New York, United States
Rival Readout
Competing with Revivo Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
United States
Himuka AM Pharma / Himuka AM Australia
Himuka is a clinical-stage biotech company, and conducting a Phase 1 clinical trial in Aus...
Miyazaki, Japan
Biscayne Neurotherapeutics Inc
A clinical-stage biotechnology company advancing innovative therapies for challenging neur...
Miami, United States
ASLAN Pharmaceuticals
A clinical-stage immunology focused biopharmaceutical company.
Singapore, Singapore
Pacylex Pharmaceuticals, Inc.
A new target in cancer care - triggering selective lethality with a new class of drugs.
Edmonton, Canada
Blueberry Therapeutics Ltd
Topical nanomedicines for treating dermatological conditions
Macclesfield, United King...
AXON Neuroscience
Independent clinical stage biotech company.
Bratislava, Slovakia
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
About Revivo Therapeutics
Revivo Therapeutics is a clinical stage biotechnology company based in the United States that is spearheading the development of a new class of drugs targeting cognitive decline. With their pioneering approach, their first drug candidate, RIV-5061, aims to address the treatment of Mild Cognitive Impairment. Currently,...
Clinical Stage, Drug Development, Cognitive Decline, Small Molecules, Mild Cognitive Impairment, Phase 1/1b Trials, Neuroscience, Pharmaceuticals, Cognitive Enhancement
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Revivo Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Revivo Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
